Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Sep 15, 2022; 14(9): 1675-1688
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1675
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1675
Figure 3 Expression patterns of six-transmembrane epithelial antigen of the prostate 4 in different subtypes of colorectal cancer.
A: Colon adenocarcinoma; B: Rectal adenocarcinoma. MSI-H: Microsatellite instability-high; MSI-L: Microsatellite instability-low; MSS: Microsatellite stable; STEAP4: Six-transmembrane epithelial antigen of the prostate 4; COAD: Colon adenocarcinoma; READ: Rectal adenocarcinoma.
- Citation: Fang ZX, Li CL, Chen WJ, Wu HT, Liu J. Potential of six-transmembrane epithelial antigen of the prostate 4 as a prognostic marker for colorectal cancer. World J Gastrointest Oncol 2022; 14(9): 1675-1688
- URL: https://www.wjgnet.com/1948-5204/full/v14/i9/1675.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i9.1675